graham & phipps, LLC

341 e 62nd st.
apt1a
new york, new york 10065

NYS Entity Status
ACTIVE

NYS Filing Date
FEBRUARY 19, 2013

NYS DOS ID#
4361932

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
JEROME PHIPPS
341 E 62ND ST.
APT1A
NEW YORK, NEW YORK, 10065

NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY

Name History
2013 - GRAHAM & PHIPPS, LLC









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • The Top 10 Moments of New York Fashion Week
    By THE NEW YORK TIMES - Friday Sep 15, 2017

    Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.

    Source: NYT > Home Page
  • Women of Sex Tech, Unite
    By ANNA NORTH - Friday Aug 18, 2017

    New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.

    Source: NYT > Home Page
  • Fit City: Taking Night-Life Cue, Gyms Lower the Lights
    By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017

    Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.

    Source: NYT > Home Page
  • Graham vows ‘holy hell’ if Trump fires Sessions
    By Mark Moore - Thursday Jul 27, 2017

    Republican Sen. Lindsey Graham on Thursday warned President Trump not to take any action against the attorney general or the special counsel investigation Russian interference in the 2016 election, saying it could be the “beginning of the end” of his presidency. “If Jeff Sessions is fired there will be holy hell to pay,” Graham (R-SC)...

    Source: New York Post: News
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Anne Graham Lotz: God & you
    By foxnewsonline@foxnews.com (Fox News Online) - Saturday Sep 16, 2017

    Source: Fox News